| UniProt ID | ABI2_HUMAN | |
|---|---|---|
| UniProt AC | Q9NYB9 | |
| Protein Name | Abl interactor 2 | |
| Gene Name | ABI2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 513 | |
| Subcellular Localization |
Cytoplasm. Isoform 1: Cell projection, lamellipodium. Cell projection, filopodium. Cytoplasm, cytoskeleton. Isoform 1 but not isoform 3 is localized to protruding lamellipodia and filopodia tips.. |
|
| Protein Description | May act in regulation of cell growth and transformation by interacting with nonreceptor tyrosine kinases ABL1 and/or ABL2. Part of the WAVE complex that regulates lamellipodia formation. The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex. Regulates ABL1/c-Abl-mediated phosphorylation of MENA. As component of the WAVE1 complex, required for BDNF-NTRK2 endocytic trafficking and signaling from early endosomes (By similarity).. | |
| Protein Sequence | MAELQMLLEEEIPGGRRALFDSYTNLERVADYCENNYIQSADKQRALEETKAYTTQSLASVAYLINTLANNVLQMLDIQASQLRRMESSINHISQTVDIHKEKVARREIGILTTNKNTSRTHKIIAPANLERPVRYIRKPIDYTILDDIGHGVKWLLRFKVSTQNMKMGGLPRTTPPTQKPPSPPMSGKGTLGRHSPYRTLEPVRPPVVPNDYVPSPTRNMAPSQQSPVRTASVNQRNRTYSSSGSSGGSHPSSRSSSRENSGSGSVGVPIAVPTPSPPSVFPAPAGSAGTPPLPATSASAPAPLVPATVPSSTAPNAAAGGAPNLADGFTSPTPPVVSSTPPTGHPVQFYSMNRPASRHTPPTIGGSLPYRRPPSITSQTSLQNQMNGGPFYSQNPVSDTPPPPPPVEEPVFDESPPPPPPPEDYEEEEAAVVEYSDPYAEEDPPWAPRSYLEKVVAIYDYTKDKEDELSFQEGAIIYVIKKNDDGWYEGVMNGVTGLFPGNYVESIMHYSE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 23 | Phosphorylation | RRALFDSYTNLERVA HHHHHHHCCCHHHHH | 11.07 | 22817900 | |
| 32 | Phosphorylation | NLERVADYCENNYIQ CHHHHHHHHHHCCCC | 7.60 | 22817900 | |
| 40 | Phosphorylation | CENNYIQSADKQRAL HHHCCCCHHHHHHHH | 28.95 | 30631047 | |
| 43 | Ubiquitination | NYIQSADKQRALEET CCCCHHHHHHHHHHH | 41.21 | - | |
| 88 | Phosphorylation | SQLRRMESSINHISQ HHHHHHHHHHHHHHH | 27.46 | 28348404 | |
| 89 | Phosphorylation | QLRRMESSINHISQT HHHHHHHHHHHHHHH | 17.69 | 28348404 | |
| 123 | Ubiquitination | KNTSRTHKIIAPANL CCCCCCEEEECCCCC | 34.88 | - | |
| 139 | Ubiquitination | RPVRYIRKPIDYTIL CCHHHCCCCCCEEEE | 36.45 | - | |
| 162 | Phosphorylation | WLLRFKVSTQNMKMG HHHEEEEECCCCCCC | 25.51 | 28122231 | |
| 163 | Phosphorylation | LLRFKVSTQNMKMGG HHEEEEECCCCCCCC | 27.27 | 28122231 | |
| 167 | Ubiquitination | KVSTQNMKMGGLPRT EEECCCCCCCCCCCC | 41.78 | - | |
| 174 | Phosphorylation | KMGGLPRTTPPTQKP CCCCCCCCCCCCCCC | 41.54 | 23927012 | |
| 175 | Phosphorylation | MGGLPRTTPPTQKPP CCCCCCCCCCCCCCC | 28.66 | 25159151 | |
| 178 | Phosphorylation | LPRTTPPTQKPPSPP CCCCCCCCCCCCCCC | 50.89 | 30266825 | |
| 183 | Phosphorylation | PPTQKPPSPPMSGKG CCCCCCCCCCCCCCC | 50.60 | 25159151 | |
| 187 | Phosphorylation | KPPSPPMSGKGTLGR CCCCCCCCCCCCCCC | 43.03 | 30266825 | |
| 191 | Phosphorylation | PPMSGKGTLGRHSPY CCCCCCCCCCCCCCC | 29.53 | 28176443 | |
| 196 | Phosphorylation | KGTLGRHSPYRTLEP CCCCCCCCCCCCCCC | 23.43 | 28176443 | |
| 198 | Phosphorylation | TLGRHSPYRTLEPVR CCCCCCCCCCCCCCC | 21.17 | 28176443 | |
| 200 | Phosphorylation | GRHSPYRTLEPVRPP CCCCCCCCCCCCCCC | 29.63 | 27273156 | |
| 205 (in isoform 3) | Phosphorylation | - | 40.29 | 27251275 | |
| 205 | Methylation | YRTLEPVRPPVVPND CCCCCCCCCCCCCCC | 40.29 | - | |
| 206 (in isoform 3) | Phosphorylation | - | 26.69 | 27251275 | |
| 207 (in isoform 3) | Phosphorylation | - | 29.22 | 27251275 | |
| 211 (in isoform 3) | Phosphorylation | - | 41.45 | 27251275 | |
| 213 (in isoform 3) | Phosphorylation | - | 22.39 | 27251275 | |
| 213 | Phosphorylation | PPVVPNDYVPSPTRN CCCCCCCCCCCCCCC | 22.39 | 27273156 | |
| 215 (in isoform 3) | Phosphorylation | - | 28.50 | 27251275 | |
| 216 | Phosphorylation | VPNDYVPSPTRNMAP CCCCCCCCCCCCCCC | 28.94 | 25159151 | |
| 218 | Phosphorylation | NDYVPSPTRNMAPSQ CCCCCCCCCCCCCCC | 38.73 | 30183078 | |
| 224 (in isoform 3) | Phosphorylation | - | 31.17 | 29523821 | |
| 224 | Phosphorylation | PTRNMAPSQQSPVRT CCCCCCCCCCCCCEE | 31.17 | 29255136 | |
| 226 (in isoform 3) | Phosphorylation | - | 54.78 | 25850435 | |
| 227 | Phosphorylation | NMAPSQQSPVRTASV CCCCCCCCCCEECCC | 20.09 | 19664994 | |
| 229 (in isoform 3) | Phosphorylation | - | 11.70 | 25850435 | |
| 230 | Methylation | PSQQSPVRTASVNQR CCCCCCCEECCCCCC | 28.14 | - | |
| 231 | Phosphorylation | SQQSPVRTASVNQRN CCCCCCEECCCCCCC | 24.42 | 27422710 | |
| 233 | Phosphorylation | QSPVRTASVNQRNRT CCCCEECCCCCCCCE | 22.46 | 18641825 | |
| 239 (in isoform 3) | Phosphorylation | - | 36.91 | 25850435 | |
| 240 | Phosphorylation | SVNQRNRTYSSSGSS CCCCCCCEECCCCCC | 31.16 | 22360455 | |
| 240 (in isoform 3) | Phosphorylation | - | 31.16 | 25849741 | |
| 241 | Phosphorylation | VNQRNRTYSSSGSSG CCCCCCEECCCCCCC | 11.88 | 24043423 | |
| 242 | Phosphorylation | NQRNRTYSSSGSSGG CCCCCEECCCCCCCC | 19.88 | 23401153 | |
| 243 | Phosphorylation | QRNRTYSSSGSSGGS CCCCEECCCCCCCCC | 28.45 | 21955146 | |
| 244 | Phosphorylation | RNRTYSSSGSSGGSH CCCEECCCCCCCCCC | 36.43 | 27273156 | |
| 246 (in isoform 3) | Phosphorylation | - | 27.97 | 29523821 | |
| 246 | Phosphorylation | RTYSSSGSSGGSHPS CEECCCCCCCCCCCC | 27.97 | 28152594 | |
| 247 | Phosphorylation | TYSSSGSSGGSHPSS EECCCCCCCCCCCCC | 51.18 | 28152594 | |
| 250 (in isoform 2) | Phosphorylation | - | 35.43 | 27251275 | |
| 250 | Phosphorylation | SSGSSGGSHPSSRSS CCCCCCCCCCCCCCC | 35.43 | 28450419 | |
| 251 (in isoform 2) | Phosphorylation | - | 29.54 | 27251275 | |
| 252 (in isoform 2) | Phosphorylation | - | 35.38 | 27251275 | |
| 253 | Phosphorylation | SSGGSHPSSRSSSRE CCCCCCCCCCCCCCC | 32.72 | 28450419 | |
| 254 | Phosphorylation | SGGSHPSSRSSSREN CCCCCCCCCCCCCCC | 40.40 | 28450419 | |
| 256 | Phosphorylation | GSHPSSRSSSRENSG CCCCCCCCCCCCCCC | 34.31 | 23898821 | |
| 256 (in isoform 2) | Phosphorylation | - | 34.31 | 27251275 | |
| 258 (in isoform 2) | Phosphorylation | - | 44.88 | 27251275 | |
| 260 (in isoform 2) | Phosphorylation | - | 58.66 | 27251275 | |
| 269 (in isoform 2) | Phosphorylation | - | 2.65 | 29523821 | |
| 271 (in isoform 2) | Phosphorylation | - | 5.84 | 25850435 | |
| 274 (in isoform 2) | Phosphorylation | - | 29.57 | 25850435 | |
| 284 (in isoform 2) | Phosphorylation | - | 8.63 | 25850435 | |
| 285 (in isoform 2) | Phosphorylation | - | 37.07 | 25849741 | |
| 291 (in isoform 2) | Phosphorylation | - | 22.81 | 29523821 | |
| 297 | Phosphorylation | GTPPLPATSASAPAP CCCCCCCCCCCCCCC | 23.92 | 20068231 | |
| 309 (in isoform 2) | Phosphorylation | - | 27.21 | 28348404 | |
| 311 (in isoform 2) | Phosphorylation | - | 20.43 | 28348404 | |
| 312 (in isoform 2) | Phosphorylation | - | 35.66 | 28348404 | |
| 314 (in isoform 2) | Phosphorylation | - | 50.93 | 28348404 | |
| 315 (in isoform 2) | Phosphorylation | - | 9.41 | 28348404 | |
| 351 | Phosphorylation | TGHPVQFYSMNRPAS CCCCCEEEECCCCCC | 7.01 | - | |
| 352 | Phosphorylation | GHPVQFYSMNRPASR CCCCEEEECCCCCCC | 15.74 | 20068231 | |
| 361 | Phosphorylation | NRPASRHTPPTIGGS CCCCCCCCCCCCCCC | 29.83 | 29255136 | |
| 364 | Phosphorylation | ASRHTPPTIGGSLPY CCCCCCCCCCCCCCC | 33.20 | 30266825 | |
| 368 | Phosphorylation | TPPTIGGSLPYRRPP CCCCCCCCCCCCCCC | 22.43 | 29255136 | |
| 371 | Phosphorylation | TIGGSLPYRRPPSIT CCCCCCCCCCCCCCC | 25.25 | 23927012 | |
| 376 | Phosphorylation | LPYRRPPSITSQTSL CCCCCCCCCCCCHHH | 40.98 | 51457467 | |
| 460 | Phosphorylation | LEKVVAIYDYTKDKE HHHHHEEEECCCCCC | 7.99 | 25159151 | |
| 462 | Phosphorylation | KVVAIYDYTKDKEDE HHHEEEECCCCCCCC | 9.94 | 28060719 | |
| 463 | Phosphorylation | VVAIYDYTKDKEDEL HHEEEECCCCCCCCC | 29.84 | - | |
| 466 | Acetylation | IYDYTKDKEDELSFQ EEECCCCCCCCCCCC | 69.49 | 19812139 | |
| 482 | Acetylation | GAIIYVIKKNDDGWY CCEEEEEEECCCCHH | 35.16 | 19812153 | |
| 504 | Phosphorylation | TGLFPGNYVESIMHY CCCCCCCHHHHHHCC | 16.12 | - | |
| 507 | Phosphorylation | FPGNYVESIMHYSE- CCCCHHHHHHCCCC- | 18.37 | 27251275 | |
| 512 | Phosphorylation | VESIMHYSE------ HHHHHCCCC------ | 23.35 | 22617229 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ABI2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ABI2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227, AND MASSSPECTROMETRY. | |
| "An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-213, AND MASSSPECTROMETRY. | |